ARDS Biologics

Focused on regenerative respiratory medicine.

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.

https://academic.oup.com/stcltm/article/10/5/660/6404151